The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer
Abstract
In tumorous tissues, the absence of vasculature supportive tissues intimates the formation of leaky vessels and pores (100 nm to 2 μm in diameter) and the poor lymphatic system offers great opportunity to treat cancer and the phenomenon is known as Enhanced permeability and retention (EPR) effect. The trends in treating cancer by making use of EPR effect is increasing day by day and generate multitudes of possibility to design novel anticancer therapeutics. This review aimed to present various factors affecting the EPR effect along with important things to know about EPR effect such as tumor perfusion, lymphatic function, interstitial penetration, vascular permeability, nanoparticle retention etc. This manuscript expounds the current advances and cross-talks the developments made in the of EPR effect-based therapeutics in cancer therapy along with a transactional view of its current clinical and industrial aspects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Microtubule-binding agents: a dynamic field of cancer therapeutics
Dumontet, C., & Jordan, M. A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3253 · Cited by 1,718
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,663
Pharmacokinetics and Biodistribution of Nanoparticles
Li, S.-D., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,568
Lymphangiogenesis: Molecular Mechanisms and Future Promise
Tammela, T., & Alitalo, K. (2010) · Cell · doi:10.1016/j.cell.2010.01.045 · Cited by 1,441
Barua, S., & Mitragotri, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.008 · Cited by 1,257
Goel, H. L., & Mercurio, A. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3627 · Cited by 1,253
Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Maeda, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.002 · Cited by 1,179
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Weissleder, R. (2006) · Science · doi:10.1126/science.1125949 · Cited by 1,112
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,101
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Wong, C., Stylianopoulos, T., Cui, J., Martin, J., Chauhan, V. P., Jiang, W., Popović, Z., Jain, R. K., Bawendi, M. G., & Fukumura, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018382108 · Cited by 1,062
A review on phospholipids and their main applications in drug delivery systems
Li, J., Wang, X., Zhang, T., Wang, C., Huang, Z., Luo, X., & Deng, Y. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.09.004 · Cited by 1,003
Kobayashi, H., Watanabe, R., & Choyke, P. L. (2014) · Theranostics · doi:10.7150/thno.7193 · Cited by 996
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Gotwals, P., Cameron, S., Cipolletta, D., Cremasco, V., Crystal, A., Hewes, B., Mueller, B., Quaratino, S., Sabatos-Peyton, C., Petruzzelli, L., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.17 · Cited by 953
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Oerlemans, C., Bult, W., Bos, M., Storm, G., Nijsen, J. F. W., & Hennink, W. E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0233-4 · Cited by 947
Enhanced Permeability and Retention (EPR) Effect for Anticancer Nanomedicine Drug Targeting
Greish, K. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-609-2_3 · Cited by 841
A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics
Steichen, S. D., Caldorera-Moore, M., & Peppas, N. A. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.006 · Cited by 751
Tumor necrosis factor and cancer, buddies or foes?
Wang, X., & Lin, Y. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00889.x · Cited by 730
Specialization of tumour vasculature
Ruoslahti, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc724 · Cited by 722
Kim, J., Cho, H. R., Jeon, H., Kim, D., Song, C., Lee, N., Choi, S. H., & Hyeon, T. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05559 · Cited by 707
New horizons in tumor microenvironment biology: challenges and opportunities
Chen, F., Zhuang, X., Lin, L., Yu, P., Wang, Y., Shi, Y., Hu, G., & Sun, Y. (2015) · BMC Medicine · doi:10.1186/s12916-015-0278-7 · Cited by 704
Polymeric nanoparticles for targeted drug delivery system for cancer therapy
Masood, F. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2015.11.067 · Cited by 702
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Palmerston Mendes, L., Pan, J., & Torchilin, V. (2017) · Molecules · doi:10.3390/molecules22091401 · Cited by 701
Substantial contribution of extrinsic risk factors to cancer development
Wu, S., Powers, S., Zhu, W., & Hannun, Y. A. (2016) · Nature · doi:10.1038/nature16166 · Cited by 666
Senger, D. R., Perruzzi, C. A., Feder, J., & Dvorak, H. F. (1986) · PubMed · Cited by 646
Investigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency
Sykes, E. A., Chen, J., Zheng, G., & Chan, W. C. W. (2014) · ACS Nano · doi:10.1021/nn500299p · Cited by 635
Nitric oxide and cancer: a review
Korde Choudhari, S., Chaudhary, M., Bagde, S., Gadbail, A. R., & Joshi, V. (2013) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-11-118 · Cited by 634
Cancer prevention from the perspective of global cancer burden patterns
Nagai, H., & Kim, Y. H. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.02.75 · Cited by 621
Siemann, D. W. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.05.001 · Cited by 611
Greish, K. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701539584 · Cited by 600
Nanotherapeutics to Overcome Conventional Cancer Chemotherapy Limitations
Chidambaram, M., Manavalan, R., & Kathiresan, K. (2011) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j30c7d · Cited by 566
Targeting Microtubules by Natural Agents for Cancer Therapy
Mukhtar, E., Adhami, V. M., & Mukhtar, H. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0791 · Cited by 565
Magnetic nanoparticle-based hyperthermia for cancer treatment
Bañobre-López, M., Teijeiro, A., & Rivas, J. (2013) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2013.09.011 · Cited by 545
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
Dendrimers: properties and applications.
Klajnert, B., & Bryszewska, M. (2001) · Acta Biochimica Polonica · doi:10.18388/abp.2001_5127 · Cited by 526
History of Cancer, Ancient and Modern Treatment Methods
Sudhakar, A. (2009) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.100000e2 · Cited by 504
Cancer and the tumor microenvironment: a review of an essential relationship
Mbeunkui, F., & Johann, D. J. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0881-9 · Cited by 487
Dendrimers in Oncology: An Expanding Horizon
Tekade, R. K., Kumar, P. V., & Jain, N. K. (2009) · Chemical Reviews · doi:10.1021/cr068212n · Cited by 466
Self-citationPolymeric nanoparticles for targeted treatment in oncology: current insights
Joshi, M. D., Patravale, V., & Prabhu, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s56932 · Cited by 438
Dimcevski, G., Kotopoulis, S., Bjånes, T., Hoem, D., Schjøtt, J., Gjertsen, B. T., Biermann, M., Molven, A., Sorbye, H., McCormack, E., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.007 · Cited by 434
Huang, X., Peng, X., Wang, Y., Wang, Y., Shin, D. M., El-Sayed, M. A., & Nie, S. (2010) · ACS Nano · doi:10.1021/nn102055s · Cited by 427
(2013) · Seminars in Immunopathology · doi:10.1007/281.1863-2300 · Cited by 392
Interaction of tumor cells and lymphatic vessels in cancer progression
Alitalo, A., & Detmar, M. (2012) · Oncogene · doi:10.1038/onc.2011.602 · Cited by 383
Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery
Kesharwani, P., & Iyer, A. K. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.012 · Cited by 380
The yin and yang of nitric oxide in cancer progression
Burke, A. J., Sullivan, F. J., Giles, F. J., & Glynn, S. A. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt034 · Cited by 370
Vascular Permeability and Drug Delivery in Cancers
Azzi, S., Hebda, J. K., & Gavard, J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00211 · Cited by 356
Miller, M. A., Gadde, S., Pfirschke, C., Engblom, C., Sprachman, M. M., Kohler, R. H., Yang, K. S., Laughney, A. M., Wojtkiewicz, G., Kamaly, N., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac6522 · Cited by 347
Multifunctional Micellar Nanomedicine for Cancer Therapy
Blanco, E., Kessinger, C. W., Sumer, B. D., & Gao, J. (2009) · Experimental Biology and Medicine · doi:10.3181/0808-mr-250 · Cited by 332
Charrois, G. J. R., & Allen, T. M. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.03.006 · Cited by 300
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications
Xing, H., Hwang, K., & Lu, Y. (2016) · Theranostics · doi:10.7150/thno.15464 · Cited by 296
Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer
Howe, L. R. (2007) · Breast Cancer Research · doi:10.1186/bcr1678 · Cited by 293
MAEDA, H. (2012) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.88.53 · Cited by 291
Tailoring nanoparticle designs to target cancer based on tumor pathophysiology
Sykes, E. A., Dai, Q., Sarsons, C. D., Chen, J., Rocheleau, J. V., Hwang, D. M., Zheng, G., Cramb, D. T., Rinker, K. D., & Chan, W. C. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521265113 · Cited by 281
Hansen, A. E., Petersen, A. L., Henriksen, J. R., Boerresen, B., Rasmussen, P., Elema, D. R., Rosenschöld, P. M. A., Kristensen, A. T., Kjær, A., & Andresen, T. L. (2015) · ACS Nano · doi:10.1021/acsnano.5b01324 · Cited by 277
Magnetic Iron Oxide Nanoparticles for Multimodal Imaging and Therapy of Cancer
Thomas, R., Park, I.-K., & Jeong, Y. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140815910 · Cited by 271
(1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/67.3.663 · Cited by 268
The Lymphatic System in Disease Processes and Cancer Progression
Padera, T. P., Meijer, E. F. J., & Munn, L. L. (2016) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-112315-031200 · Cited by 248
Nanotechnology in Cancer Drug Delivery and Selective Targeting
Sutradhar, K. B., & Amin, M. L. (2014) · ISRN Nanotechnology · doi:10.1155/2014/939378 · Cited by 241
Heme oxygenase-1: emerging target of cancer therapy
Chau, L.-Y. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0128-0 · Cited by 237
Tumor Vasculature Targeted Photodynamic Therapy for Enhanced Delivery of Nanoparticles
Zhen, Z., Tang, W., Chuang, Y.-J., Todd, T., Zhang, W., Lin, X., Niu, G., Liu, G., Wang, L., Pan, Z., et al. (2014) · ACS Nano · doi:10.1021/nn501134q · Cited by 228
Kotopoulis, S., Dimcevski, G., Helge Gilja, O., Hoem, D., & Postema, M. (2013) · Medical Physics · doi:10.1118/1.4808149 · Cited by 226
Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment
Ibsen, S., Schutt, & Esener (2013) · Drug Design, Development and Therapy · doi:10.2147/dddt.s31564 · Cited by 219
Wang, Y., Probin, V., & Zhou, D. (2006) · Current Cancer Therapy Reviews · doi:10.2174/157339406777934717 · Cited by 213
Cancer-Associated Thrombosis: An Overview
Elyamany, G., Alzahrani, A. M., & Bukhary, E. (2014) · Clinical Medicine Insights: Oncology · doi:10.4137/cmo.s18991 · Cited by 209
Future of the Particle Replication in Nonwetting Templates (PRINT) Technology
Xu, J., Wong, D. H. C., Byrne, J. D., Chen, K., Bowerman, C., & DeSimone, J. M. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209145 · Cited by 208
de Wilt, J. H. W., ten Hagen, T. L. M., de Boeck, G., van Tiel, S. T., de Bruijn, E. A., & Eggermont, A. M. M. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1032 · Cited by 207
Tumour necrosis factor and cancer
Waters, J. P., Pober, J. S., & Bradley, J. R. (2013) · The Journal of Pathology · doi:10.1002/path.4188 · Cited by 206
Li, Q.-L., Sun, Y., Sun, Y.-L., Wen, J., Zhou, Y., Bing, Q.-M., Isaacs, L. D., Jin, Y., Gao, H., & Yang, Y.-W. (2014) · Chemistry of Materials · doi:10.1021/cm503304p · Cited by 191
Onivyde for the therapy of multiple solid tumors
Zhang, H. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s105587 · Cited by 187
Tumor targeting using liposomal antineoplastic drugs
Huwyler, J. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s1253 · Cited by 182
Nanotechnology-based approaches for targeting and delivery of drugs and genes
Mishra, V. K., Kesharwani, P., Amin, M. C. I. M., & Iyer, A. K. (2017) · Cited by 181
Nagamitsu, A., Greish, K., & Maeda, H. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp074 · Cited by 180
Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application
Seki, T., Fang, J., & Maeda, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01323.x · Cited by 179
Lymphatic vessels in cancer metastasis: bridging the gaps
Shayan, R. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl031 · Cited by 173
Heneweer, C., Holland, J. P., Divilov, V., Carlin, S., & Lewis, J. S. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.083998 · Cited by 172
Charrois, G. J. R., & Allen, T. M. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00661-2 · Cited by 170
Yasuda, H., Yamaya, M., Nakayama, K., Sasaki, T., Ebihara, S., Kanda, A., Asada, M., Inoue, D., Suzuki, T., Okazaki, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0436 · Cited by 170
Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies
Xie, Y., Bagby, T. R., Cohen, M., & Forrest, M. L. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903085128 · Cited by 169
Clark, A. J., Wiley, D. T., Zuckerman, J. E., Webster, P., Chao, J., Lin, J., Yen, Y., & Davis, M. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603018113 · Cited by 168
Tumor Necrosis Factor-α Is a Potent Endogenous Mutagen that Promotes Cellular Transformation
Yan, B., Wang, H., Rabbani, Z. N., Zhao, Y., Li, W., Yuan, Y., Li, F., Dewhirst, M. W., & Li, C.-Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2540 · Cited by 165
Lu, D., Tang, C., Chen, Y., & Wei, I. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22580 · Cited by 161
Interstitial Fluid Flow and Drug Delivery in Vascularized Tumors: A Computational Model
Welter, M., & Rieger, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070395 · Cited by 158
Parameters Affecting the Enhanced Permeability and Retention Effect: The Need for Patient Selection
Natfji, A. A., Ravishankar, D., Osborn, H. M. I., & Greco, F. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.06.019 · Cited by 155
Dendrimers: design, synthesis and chemical properties
Boas, U., Christensen, J. B., & Heegaard, P. M. H. (2006) · Journal of Materials Chemistry · doi:10.1039/b611813p · Cited by 153
van Vlerken, L. E., Duan, Z., Little, S. R., Seiden, M. V., & Amiji, M. M. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800030k · Cited by 152
Optical Imaging of Cancer Heterogeneity with Multispectral Optoacoustic Tomography
Herzog, E., Taruttis, A., Bézière, N., Lutich, A. A., Razansky, D., & Ntziachristos, V. (2012) · Radiology · doi:10.1148/radiol.11111646 · Cited by 151
Dai, J., Kitagawa, Y., Zhang, J., Yao, Z., Mizokami, A., Cheng, S., Nor, J. E., McCauley, L. K., Taichman, R. S., & Keller, E. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1382 · Cited by 147
Liu, Y., Yang, F., Yuan, C., Li, M., Wang, T., Chen, B., Jin, J., Zhao, P., Tong, J., Luo, S., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06815 · Cited by 145
The Potential Role of Nitric Oxide in Halting Cancer Progression Through Chemoprevention
Vahora, H., Khan, M. A., ALAlami, U., & Hussain, A. (2016) · Journal of Cancer Prevention · doi:10.15430/jcp.2016.21.1.1 · Cited by 136
Muniswamy, V. J., Raval, N., Gondaliya, P., Tambe, V., Kalia, K., & Tekade, R. K. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.035 · Cited by 136
Self-citationNakamura, Y., Yasuoka, H., Tsujimoto, M., Yoshidome, K., Nakahara, M., Nakao, K., Nakamura, M., & Kakudo, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1269 · Cited by 133
Sousa, F., Cruz, A., Fonte, P., Pinto, I. M., Neves‐Petersen, M. T., & Sarmento, B. F. C. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-03959-4 · Cited by 128
Advances in Fluorescence Imaging Techniques to Detect Oral Cancer and Its Precursors
Shin, D., Vigneswaran, N., Gillenwater, A. M., & Richards-Kortum, R. R. (2010) · Future Oncology · doi:10.2217/fon.10.79 · Cited by 123
Current Status of Hybrid PET/MRI in Oncologic Imaging
Rosenkrantz, A. B., Friedman, K. P., Chandarana, H., Melsaether, A. N., Moy, L. P., Ding, Y., Jhaveri, K. L., Beltrán, L., & Jain, R. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.15.14968 · Cited by 121
The Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton
Wanicek, E., Cossigny, D. A. F., & Quan, G. M. Y. (2013) · Prostate Cancer · doi:10.1155/2013/418340 · Cited by 121
Improving nanoparticle diffusion through tumor collagen matrix by photo-thermal gold nanorods
Raeesi, V., & Chan, W. C. W. (2016) · Nanoscale · doi:10.1039/c5nr08463f · Cited by 121
PET/CT in Oncology: Current Status and Perspectives
Czernin, J. G., Allen-Auerbach, M., Nathanson, D. A., & Herrmann, K. (2013) · Current Radiology Reports · doi:10.1007/s40134-013-0016-x · Cited by 113
Baronzio, G., Parmar, G., & Baronzio, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00165 · Cited by 105
Size Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor Delivery
Tong, X., Wang, Z., Sun, X., Song, J., Jacobson, O., Niu, G., Kiesewetter, D. O., & Chen, X. S. (2016) · Theranostics · doi:10.7150/thno.17098 · Cited by 103
Breast cancer metastasis and the lymphatic system
Rahman, M., & Mohammed, S. I. (2015) · Oncology Letters · doi:10.3892/ol.2015.3486 · Cited by 101
Siemens, D. R., Heaton, J. P. W., Adams, M. A., Kawakami, J., & Graham, C. H. (2009) · Urology · doi:10.1016/j.urology.2009.03.004 · Cited by 100
Positron emission tomography (PET): Expanding the horizons of oncology drug development
Hammond, L. A., Denis, L., Salman, U. A., Jerabek, P., Thomas, C. R., & Kuhn, J. G. (2003) · Investigational New Drugs · doi:10.1023/a:1025468611547 · Cited by 96
Nanoparticle Encapsulation of Mitaplatin and the Effect Thereof onIn VivoProperties
Johnstone, T. C., Kulak, N., Pridgen, E. M., Farokhzad, O. C., Langer, R., & Lippard, S. J. (2013) · ACS Nano · doi:10.1021/nn401905g · Cited by 96
Vigor, K., Kyrtatos, P. G., Minogue, S., Al‐Jamal, K. T., Kogelberg, H., Tolner, B., Kostarelos, K., Beǵent, R. H. J., Pankhurst, Q. A., Lythgoe, M. F., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.10.036 · Cited by 95
Nitric Oxide for Cancer Therapy
Huerta, S. (2015) · Future Science OA · doi:10.4155/fso.15.44 · Cited by 94
Yu, B., Goel, S., Ni, D., Ellison, P. A., Siamof, C. M., Jiang, D., Cheng, L., Kang, L., Yu, F., Liu, Z., et al. (2018) · Advanced Materials · doi:10.1002/adma.201704934 · Cited by 94
Fang, J. Q., Qin, H., Nakamura, H., Tsukigawa, K., Shin, T., & Maeda, H. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02178.x · Cited by 88
Gao, X., Zhang, J., Huang, Z., Zuo, T., Lu, Q., Wu, G., & Shen, Q. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b05119 · Cited by 87
Shenoi, M. M., Iltis, I., Choi, J., Koonce, N. A., Metzger, G. J., Griffin, R. J., & Bischof, J. C. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300505w · Cited by 83
Otterbein, L. E., Hedblom, A., Harris, C. E., Csizmadia, E., Gallo, D. J., & Wegiel, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102295108 · Cited by 80
Biopolymer-based nanocomposites for transdermal drug delivery
Tekade, R. K., Maheshwari, R., & Tekade, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-101914-6.00004-1 · Cited by 80
Self-citationThe Effects of Nanoparticle Drug Loading on the Pharmacokinetics of Anticancer Agents
Petschauer, J. S., Madden, A. J., Kirschbrown, W. P., Song, G. K., & Zamboni, W. C. (2015) · Nanomedicine · doi:10.2217/nnm.14.179 · Cited by 79
The Use of Ultrasound and Micelles in Cancer Treatment
Husseini, G. A., & Pitt, W. G. (2008) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2008.225 · Cited by 75
The Role of Magnetic Nanoparticles in the Localization and Treatment of Breast Cancer
Ahmed, M., & Douek, M. (2013) · BioMed Research International · doi:10.1155/2013/281230 · Cited by 75
Ran, R., Wang, H., Liu, Y., Hui, Y., Sun, Q., Seth, A., Wibowo, D., Chen, D., & Zhao, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.06.017 · Cited by 75
Sathyamoorthy, N., Dhanaraju, M. D., Sundar, V. D., & Heera, B. (2017) · Bulletin of Faculty of Pharmacy Cairo University · doi:10.1016/j.bfopcu.2017.06.003 · Cited by 73
Lu, D., Leung, Y., Huang, S.-M., & Wong, K. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22520 · Cited by 71
Polymeric Micelles for Neoadjuvant Cancer Therapy and Tumor-Primed Optical Imaging
Cho, H., & Kwon, G. S. (2011) · ACS Nano · doi:10.1021/nn202676u · Cited by 69
Lymph Nodes and Cancer Metastasis: New Perspectives on the Role of Intranodal Lymphatic Sinuses
Ji, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010051 · Cited by 68
Tanaka, S., Akaike, T., Wu, J., Fang, J. Q., Sawa, T., Ogawa, M., Beppu, T., & Maeda, H. (2003) · Journal of drug targeting · doi:10.1080/1061186031000086072 · Cited by 59
Positron Emission Tomography in oncology: Present and future of PET and PET/CT
Papathanassiou, D., Bruna-Muraille, C., Liehn, J., Nguyen, T. D., & Curé, H. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.10.006 · Cited by 58
Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib
Taylor, S. J., Duyvestyn, J. M., Dagger, S. A., Dishington, E. J., Rinaldi, C., Dovey, O. M., Vassiliou, G. S., Grove, C. S., & Langdon, W. Y. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam8060 · Cited by 53
Yu, H., Wang, S., Chang, A., Tai, H., Yeh, H., Lin, Y., & Tang, C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.10.016 · Cited by 52
Antiangiogenesis Enhances Intratumoral Drug Retention
Ma, J., Chen, C.-S., Blute, T. A., & Waxman, D. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3242 · Cited by 51
Bradykinin stimulates IL-6 production and cell invasion in colorectal cancer cells
Wang, G., Ye, Y., Zhang, X., & Song, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3366 · Cited by 51
van Etten, B., de Vries, M. R., van Ijken, M. G. A., Lans, T. E., Guetens, G., Ambagtsheer, G., van Tiel, S. T., Boeck, G. D., de Bruijn, E. A., Eggermont, A. M. M., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600707 · Cited by 50
Dort, M. V., Rehemtulla, A., & Ross, B. D. (2008) · Current Computer - Aided Drug Design · doi:10.2174/157340908783769265 · Cited by 49
A Potential Role of Bradykinin in Angiogenesis and Growth of S-180 Mouse Tumors
Ishihara, K., Hayashi, I., Yamashina, S., & Majima, M. (2001) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.87.318 · Cited by 48
The role of magnetic resonance imaging in oncology
Hernando, C. G., Esteban, L., Cañas, T., den Brule, E. V., & Pastrana, M. (2010) · Clinical & Translational Oncology · doi:10.1007/s12094-010-0565-x · Cited by 46
Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing
Tambe, V., Thakkar, S., Raval, N., Sharma, D., Kalia, K., & Tekade, R. K. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170314104619 · Cited by 44
Self-citationLiang, X., Xu, Y., Gao, C., Zhou, Y., Zhang, N., & Dai, Z. (2018) · NPG Asia Materials · doi:10.1038/s41427-018-0066-x · Cited by 44
Carbon Nanotubes in the Delivery of Anticancer Herbal Drugs
Jogi, H., Maheshwari, R., Raval, N., Kuche, K., Tambe, V., Mak, K., Pichika, M. R., & Tekade, R. K. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0397 · Cited by 43
Self-citationFunctional magnetic resonance imaging in oncology: state of the art
Guimarães, M. D., Schuch, A., Hochhegger, B., Gross, J. L., Chojniak, R., & Marchiori, E. D. S. (2014) · Radiologia Brasileira · doi:10.1590/s0100-39842014000200013 · Cited by 41
Nagaraju, D. H., Budagumpi, S., & Yhobu, Z. (2023) · Springer eBooks · doi:10.1007/978-981-19-0710-4_18 · Cited by 41
Oncology drug development: United States Food and Drug Administration perspective
Hirschfeld, S., & Pazdur, R. M. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00008-2 · Cited by 33
Khokhlova, T. D., Haider, Y. A., & Hwang, J. H. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15592584 · Cited by 32
Yu, H., Lin, T., & Tang, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140713329 · Cited by 30
Nakamura, S., Otsuka, N., Yoshino, Y., et al. (2016) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c15-00992 · Cited by 22
Dewhirst, M. W., & Ashcraft, K. A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1292 · Cited by 22
What is the Best Treatment for a Cancer Patient with Thrombosis?
Barbosa, M. (2014) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s13386 · Cited by 15
Exposing the Tumor microenvironment: How Gold Nanoparticles Enhance and Refine Drug Delivery
Tamarkin, L., & Kingston, D. G. I. (2017) · Therapeutic Delivery · doi:10.4155/tde-2016-0095 · Cited by 11
Cited by
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00193 · Cited by 1,451
Liu, P., Chen, G., & Zhang, J. (2022) · Molecules · doi:10.3390/molecules27041372 · Cited by 1,334
“capillaries (100 nm–2 μm depending upon the size and type of tumor tissue [22]).”
BackgroundWu, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080771 · Cited by 1,030
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Emerging Applications of Nanotechnology in Healthcare and Medicine
Malik, S., Muhammad, K., & Waheed, Y. (2023) · Molecules · doi:10.3390/molecules28186624 · Cited by 610
Metadata
- Authors
- Kalyane, D., Raval, N., Maheshwari, R., Tambe, V., Kalia, K., & Tekade, R. K.
- Venue
- Materials Science and Engineering: C
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 98
- Pages
- 1252-1276
- ISSN
- 0928-4931 (ISSN-L)
- OpenAlex
- W2910346583
- Cited by
- 849
- References
- 161
- FWCI
- 25.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.